CDC s latest interim guidance recommends against use of dolutegravir DTG for

Submitted by vgreene on Tue, 10/12/2021 - 22:10
Exclude Patient Type Detail Header
No
Detail Type
Text
Patient Type Detail Header (Long)
CDC’s <a href=https://www.cdc.gov/hiv/pdf/basics/cdc-hiv-dolutegravir-alert.pdf><u>latest interim guidance</u></a> recommends against use of dolutegravir (DTG) for: